Free Republic

The U.S. is still reeling from the COVID-19 pandemic with more and more long COVID cases emerging. Bird flu is a growing threat. Measles outbreaks have been occurring. Antibiotic-resistant organisms continue to spread in healthcare settings. So what do you do next if you are in charge of the U.S. Department of Health and Human Services, which is supposed to protect the health of humans in the U.S.? How about lay off the entire staff of the U.S. government’s Office of Infectious Disease and HIV/AIDS Policy?

What St. Joseph's Hospital in Tucson is seeing in ER patientsThe pandemic has lingering effects and one of them that’s getting attention is the increased number of people dealing with newly diagnosed high blood pressure issues. KGUN 9 spoke to an expert at St. Joseph’s Hospital about new cases coming through their doors. Internist Dr. Nathaniel Rial with St. Joseph’s says he’s seeing more people come into the emergency room who find out they have new conditions like high blood pressure, diabetes and heart disease and its being diagnosed in later stages. Some of it may have been sparked by...

This document is the product of collaboration between the World Health Organization (WHO) Global Influenza Programme and the WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong.

There are many examples of HCQ efficacy in treating covid19 ie India and many US doctors advocate its use. HCQ is safe by any measure and is even given to children. Mr. President find the recent video of doctors that strongly advocate its immediate use on the general population with dramatic results YOU Mr. President can end this pandemic in a week. don't be influenced by big Pharma. Make it available now and watch the death rate tumble

While elected officials and bureaucrats go about shutting down business, entrepreneurs and the private sector will lead America and the world out of the COVID-19 pandemic. Case in point are companies such as Pulmotect Inc., a Houston-based bio-pharmaceutical company that develops products to reduce death in patients at risk of severe respiratory diseases. Pulmotect in late January announced that experiments involving its PUL-042 immune system drug showed promise in protecting against both lethal SARS-associated coronavirus and the MERS-associated coronavirus. PUL-042 is delivered as an aerosol. In tests involving mice, a single inhaled dose was shown to protect the host from...

We know the numerator, but not the denominator.” — Leading medical researcher, name withheld, discussing the statistical effect of the coronavirus 2019 One of the most difficult problems in assessing the current coronavirus 2019 (hereinafter COVID-19) pandemic is sorting through the conflicting expert opinions and the evolving statistical data that have — with an enormous assist by the mainstream media — plunged our nation into a state of panic and paralysis. How did we get here? And just how serious is the threat posed by COVID-19? I’m neither a doctor nor an epidemiologist. But as a prosecutor and trial lawyer,...